scholarly journals Exploring the use of cognitive enhancement substances among Portuguese university students

Author(s):  
Afonso Miguel Cavaco ◽  
João Ribeiro ◽  
Lotte Stig Nørgaard
2021 ◽  
pp. 147821032110619
Author(s):  
Fanny Monnet ◽  
Christina Ergler ◽  
Eva Pilot ◽  
Preeti Sushama ◽  
James Green

Qualitative work with students who use prescription medicines for academic purposes is limited. Thus, a more nuanced understanding of tertiary students’ experiences is urgently needed. Our study – which draws on five semi-structured interviews with New Zealand university students, complemented with information from local newspapers, blog entries and discussion forums – reveals students’ motivations and perceived effects, their risk perceptions and provides insights into the circumstances enabling the engagement with prescription medicines for academic purposes. Students were influenced by peers and social norms; and ideas about identity, morality and fairness also played a role for engaging with cognitive enhancers. Students used high levels of stress and workload to justify their use but took individual responsibility for their practices. By taking responsibility in this way, rather than considering it as a product of their environment, they buy into the neoliberal university discourse. Unexpectedly, some participants were already receiving medically justified psychopharmacological treatment but extended and supplemented this with nonmedical use. Others considered their use as being for academic emergencies, and that their low level of use helped manage risks. Overall, students viewed pharmacological cognitive enhancement for improving academic performance as cautious, safe, and morally acceptable. We argue in this paper that a local understanding of students’ motivations, justifications and perceptions of pharmacological cognitive enhancement is required, to tailor policies and support systems better to their needs and behaviours.


PLoS ONE ◽  
2013 ◽  
Vol 8 (7) ◽  
pp. e68821 ◽  
Author(s):  
Sebastian Sattler ◽  
Carsten Sauer ◽  
Guido Mehlkop ◽  
Peter Graeff

Author(s):  
Raissa Carolina Fonseca Cândido ◽  
Edson Perini ◽  
Cristiane Menezes de Pádua ◽  
Daniela Rezende Junqueira

2016 ◽  
Vol 26 ◽  
pp. S697-S698 ◽  
Author(s):  
R. Santacroce ◽  
F. Sarchione ◽  
O. Corazza ◽  
M. Lupi ◽  
E. Cinosi ◽  
...  

2019 ◽  
Vol 46 (4) ◽  
pp. 379-399 ◽  
Author(s):  
Aleksi Hupli ◽  
Gabija Didžiokaitė ◽  
Marte Ydema

This article examines the ambiguous relationship between treating illness and enhancing normalcy through the use of “cognitive enhancement” drugs. Although the literature on pharmacological neuro-enhancement generally differentiates between the “licit/therapeutic” and “illicit/enhancement” use of substances, in-depth interviews with 35 university students in the Netherlands and Lithuania—both with and without formal medical diagnoses of (mainly) Attention Deficit Disorder and Attention Deficit Hyperactivity Disorder—reveal the fluidity of these categories. Our study of the perceptions and experiences of people who use such drugs further suggests a much broader range of substances, motives, and sought-after effects than are commonly acknowledged in the “cognitive enhancement” literature. We need a more inclusive and context-sensitive approach to study pharmacological neuro-enhancement, for instance, by approaching both licit and illicit drugs as tools or instruments.


2012 ◽  
Vol 6 (2) ◽  
pp. 112-117 ◽  
Author(s):  
Silvana Castaldi ◽  
Umberto Gelatti ◽  
Grazia Orizio ◽  
Uwe Hartung ◽  
Ana Maria Moreno-Londono ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document